Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694196,Abfw2,Abdominal fat weight QTL 2,16.58,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),3,29682732,74682732,Rat,n/a,region,qtl 1000,8693632,Alc27,Alcohol consumption QTL 27,2.2,0.791,drinking behavior trait (VT:0001422),calculated ethanol drink intake rate (CMO:0001615),6,34257766,53855198,Rat,n/a,region,qtl 1000,12879868,Am6,Aortic mass QTL 6,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),3,31103589,72989078,Rat,n/a,region,qtl 1000,738019,Anxrr10,Anxiety related response QTL 10,3.9,,exploratory behavior trait (VT:0010471),number of entries into a discrete space in an experimental apparatus (CMO:0000960),3,40422921,85422921,Rat,n/a,region,qtl 1000,1578668,Bmd14,Bone mineral density QTL 14,3.8,,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),6,6161722,76002731,Rat,n/a,region,qtl 1000,631685,Bp118,Blood pressure QTL 118,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,24655225,69655225,Rat,n/a,region,qtl 1000,631647,Bp122,Blood pressure QTL 122,6.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,32130997,77130997,Rat,n/a,region,qtl 1000,731180,Bp152,Blood pressure QTL 152,,0.03,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,55245276,95176874,Rat,n/a,region,qtl 1000,731180,Bp152,Blood pressure QTL 152,,0.03,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),3,55245276,95176874,Rat,n/a,region,qtl 1000,731180,Bp152,Blood pressure QTL 152,,0.03,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,55245276,95176874,Rat,n/a,region,qtl 1000,1300169,Bp177,Blood pressure QTL 177,2.96,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),3,33477354,62922975,Rat,n/a,region,qtl 1000,1358885,Bp251,Blood pressure QTL 251,3.8,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,1358888,Bp264,Blood pressure QTL 264,4.43,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,2301972,Bp325,Blood pressure QTL 325,4.8,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),6,1,75623393,Rat,n/a,region,qtl 1000,61356,Bp37,Blood pressure QTL 37,3,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),3,32130997,77130997,Rat,n/a,region,qtl 1000,1578665,Bss16,Bone structure and strength QTL 16,4.4,,femur morphology trait (VT:0000559),bone trabecular cross-sectional area (CMO:0002311),6,6161722,76002731,Rat,n/a,region,qtl 1000,2293709,Bss23,Bone structure and strength QTL 23,5.18,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),6,1,43665660,Rat,n/a,region,qtl 1000,2293656,Bss28,Bone structure and strength QTL 28,6.79,0.0001,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),6,1,43665660,Rat,n/a,region,qtl 1000,2293650,Bss31,Bone structure and strength QTL 31,5.05,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),6,1,43665660,Rat,n/a,region,qtl 1000,634318,Bw118,Body weight QTL 118,3.55,,abdominal fat pad mass (VT:1000711),abdominal fat pad weight (CMO:0000088),6,36260288,60606186,Rat,n/a,region,qtl 1000,634322,Bw12,Body weight QTL 12,0,,body mass (VT:0001259),body weight (CMO:0000012),7,10173862,55173862,Rat,n/a,region,qtl 1000,7411542,Bw127,Body weight QTL 127,5.5,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),6,1,42388212,Rat,n/a,region,qtl 1000,8694386,Bw159,Body weight QTL 159,4.52,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),3,29682732,74682732,Rat,n/a,region,qtl 1000,11565451,Bw177,Body weight QTL 177,,0.002,body mass (VT:0001259),body weight (CMO:0000012),3,31103589,72989078,Rat,n/a,region,qtl 1000,1331777,Bw24,Body weight QTL 24,3.503,,body mass (VT:0001259),body weight (CMO:0000012),3,40523593,92654473,Rat,n/a,region,qtl 1000,1354589,Bw31,Body weight QTL 31,3.3,,body mass (VT:0001259),body weight (CMO:0000012),3,33477354,81136227,Rat,n/a,region,qtl 1000,1354604,Bw36,Body weight QTL 36,2.9,,body mass (VT:0001259),body weight (CMO:0000012),3,33477354,108914061,Rat,n/a,region,qtl 1000,1358293,Bw38,Body weight QTL 38,6,0.0000031,body mass (VT:0001259),body weight (CMO:0000012),3,56735995,101735995,Rat,n/a,region,qtl 1000,1582238,Bw68,Body weight QTL 68,3.2,0.0064,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,1582218,Bw74,Body weight QTL 74,3.9,0.0021,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,1582249,Bw77,Body weight QTL 77,3.2,0.0025,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),3,54630948,66711785,Rat,n/a,region,qtl 1000,631665,Bw8,Body weight QTL 8,5.5,,body mass (VT:0001259),body weight (CMO:0000012),3,51821836,124513579,Rat,n/a,region,qtl 1000,2301970,Bw81,Body weight QTL 81,5.19,,body mass (VT:0001259),body weight (CMO:0000012),3,43295930,163640485,Rat,n/a,region,qtl 1000,2302276,Bw82,Body weight QTL 82,4.32,,body mass (VT:0001259),body weight (CMO:0000012),3,40523593,64880586,Rat,n/a,region,qtl 1000,61419,Cia11,Collagen induced arthritis QTL 11,5.6,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),3,34394121,103141944,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,30846101,172879276,Rat,n/a,region,qtl 1000,1581503,Cm58,Cardiac mass QTL 58,2.7,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,45406058,127023997,Rat,n/a,region,qtl 1000,2301400,Cm68,Cardiac mass QTL 68,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),3,31103589,72989078,Rat,n/a,region,qtl 1000,2301971,Cm71,Cardiac mass QTL 71,4.63,,heart left ventricle mass (VT:0007031),heart left ventricle weight (CMO:0000776),3,43295930,163640485,Rat,n/a,region,qtl 1000,6893340,Cm77,Cardiac mass QTL 77,0.26,0.57,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),6,36260288,84763275,Rat,n/a,region,qtl 1000,631676,Cm8,Cardiac mass QTL 8,7.03,0.0001,aorta mass (VT:0002845),aorta weight (CMO:0000076),3,18023664,63023664,Rat,n/a,region,qtl 1000,12879866,Cm94,Cardiac mass QTL 94,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,31103589,72989078,Rat,n/a,region,qtl 1000,12879867,Cm95,Cardiac mass QTL 95,,0.047,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),3,31103589,72989078,Rat,n/a,region,qtl 1000,1641898,Colcr4,Colorectal carcinoma resistance QTL4,3.71,0.0007,intestine integrity trait (VT:0010554),well differentiated malignant colorectal tumor surface area measurement (CMO:0002077),6,21515302,65784818,Rat,n/a,region,qtl 1000,1354590,Despr11,Despair related QTL 11,,0.000031,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),3,29908255,74908255,Rat,n/a,region,qtl 1000,61377,Edpm3,Estrogen-dependent pituitary mass QTL 3,7.05,0.038,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,54631046,93415673,Rat,n/a,region,qtl 1000,2292589,Emca10,Estrogen-induced mammary cancer QTL 10,,0.048,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),6,1120393,46120393,Rat,n/a,region,qtl 1000,1559282,Emca5,Estrogen-induced mammary cancer QTL 5,3.9,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),3,45406058,177699992,Rat,n/a,region,qtl 1000,1576309,Emca7,Estrogen-induced mammary cancer QTL 7,4,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),6,2537030,111715717,Rat,n/a,region,qtl 1000,1582239,Epfw1,Epididymal fat weight QTL 1,4.5,0.0006,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),3,54630948,119830094,Rat,n/a,region,qtl 1000,2292613,Ept16,Estrogen-induced pituitary tumorigenesis QTL 16,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,1358186,Ept2,Estrogen-induced pituitary tumorigenesis QTL 2,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,2292591,Esta4,Estrogen-induced thymic atrophy QTL 4,,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),3,48561928,155263151,Rat,n/a,region,qtl 1000,7411603,Foco13,Food consumption QTL 13,5.5,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),6,1,42388212,Rat,n/a,region,qtl 1000,7411584,Foco4,Food consumption QTL 4,4.3,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),6,1,44015370,Rat,n/a,region,qtl 1000,2303593,Gluco46,Glucose level QTL 46,3,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,29908255,74908255,Rat,n/a,region,qtl 1000,737818,Hcar12,Hepatocarcinoma resistance QTL 12,2.6,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),3,30114912,123700444,Rat,n/a,region,qtl 1000,1358905,Hrtrt17,Heart rate QTL 17,5.9,0.000014,heart pumping trait (VT:2000009),heart rate (CMO:0000002),3,10094081,93415837,Rat,n/a,region,qtl 1000,1300178,Hrtrt4,Heart rate QTL 4,3.74,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),3,45406058,94467785,Rat,n/a,region,qtl 1000,9589129,Insul24,Insulin level QTL 24,19.06,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),6,1,42388212,Rat,n/a,region,qtl 1000,2293839,Kiddil2,Kidney dilation QTL 2,4.8,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),6,22042854,84763421,Rat,n/a,region,qtl 1000,2293841,Kiddil4,Kidney dilation QTL 4,4.4,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),6,22042854,84763421,Rat,n/a,region,qtl 1000,1354597,Kidm13,Kidney mass QTL 13,2.9,,kidney mass (VT:0002707),right kidney wet weight (CMO:0000082),3,43295930,108914061,Rat,n/a,region,qtl 1000,10401800,Kidm49,Kidney mass QTL 49,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),6,16810107,61810107,Rat,n/a,region,qtl 1000,10401812,Kidm54,Kidney mass QTL 54,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),6,16810107,61810107,Rat,n/a,region,qtl 1000,11565452,Kidm57,Kidney mass QTL 57,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,31103589,72989078,Rat,n/a,region,qtl 1000,4145119,Mcs25,Mammary carcinoma susceptibility QTL 25,,0.0001,mammary gland integrity trait (VT:0010552),ratio of deaths to total study population during a period of time (CMO:0001023),6,7009971,115379601,Rat,n/a,region,qtl 1000,2298542,Neuinf11,Neuroinflammation QTL 11,3.9,,nervous system integrity trait (VT:0010566),"spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)",3,10119318,79772001,Rat,n/a,region,qtl 1000,2302055,Pia30,Pristane induced arthritis QTL 30,3.5,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111),3,29321714,74321714,Rat,n/a,region,qtl 1000,8552950,Pigfal12,Plasma insulin-like growth factor 1 level QTL 12,7.3,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),3,29682732,74682732,Rat,n/a,region,qtl 1000,8552962,Pigfal16,Plasma insulin-like growth factor 1 level QTL 16,9.4,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),6,1,42388212,Rat,n/a,region,qtl 1000,8552910,Pigfal5,Plasma insulin-like growth factor 1 level QTL 5,4.3,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),6,19417887,64417887,Rat,n/a,region,qtl 1000,1300143,Rf14,Renal function QTL 14,2.92,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),6,34367436,80490628,Rat,n/a,region,qtl 1000,1300164,Rf15,Renal function QTL 15,3.12,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),6,13122958,57516539,Rat,n/a,region,qtl 1000,1331795,Rf30,Renal function QTL 30,3.708,,urine potassium amount (VT:0010539),urine potassium level (CMO:0000128),3,40523593,92654473,Rat,n/a,region,qtl 1000,1331779,Rf38,Renal function QTL 38,2.876,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),6,34995656,75623393,Rat,n/a,region,qtl 1000,738024,Sach5,Saccharine consumption QTL 5,3.9,0.00039,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),6,1,44570292,Rat,n/a,region,qtl 1000,9589048,Scfw3,Subcutaneous fat weight QTL 3,4.57,0.001,subcutaneous adipose mass (VT:1000472),abdominal subcutaneous fat pad weight (CMO:0002069),6,1,42388212,Rat,n/a,region,qtl 1000,2290452,Scl56,Serum cholesterol level QTL 56,2.26,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),3,1,95176874,Rat,n/a,region,qtl 1000,10450794,Scl69,Serum cholesterol level QTL 69,6.3,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,21223803,66223803,Rat,n/a,region,qtl 1000,10450804,Scl70,Serum cholesterol level QTL 70,4.7,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,21223803,66223803,Rat,n/a,region,qtl 1000,9590136,Scort3,Serum corticosterone level QTL 3,23.37,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,29682732,74682732,Rat,n/a,region,qtl 1000,1354664,Slep2,Serum leptin concentration QTL 2,4.49,,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),6,1120393,75023446,Rat,n/a,region,qtl 1000,1358362,Srcrt2,Stress Responsive Cort QTL 2,2.78,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,39248391,140271184,Rat,n/a,region,qtl 1000,724523,Tsu1,Thymus enlargement suppressive QTL 1,3.84,,thymus mass (VT:0004954),thymus weight to body weight ratio (CMO:0000612),3,51822008,120917851,Rat,n/a,region,qtl 1000,1331743,Uae28,Urinary albumin excretion QTL 28,4.5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),6,1,41917988,Rat,n/a,region,qtl 1000,9590286,Uminl1,Urine mineral level QTL 1,3.5,0.001,urine mineral amount (VT:0015086),urine electrolyte level (CMO:0000593),3,29682732,74682732,Rat,n/a,region,qtl